These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12034184)

  • 1. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
    De Greef KE; Ysebaert DK; Vercauteren SR; Chapelle T; Roeyen G; Bosmans JL; Verpooten GA; De Broe ME
    Transplant Proc; 2002 May; 34(3):791-4. PubMed ID: 12034184
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
    Ysebaert DK; De Greef KE; Vercauteren SR; Verhulst A; Kockx M; Verpooten GA; De Broe ME
    Kidney Int; 2003 Sep; 64(3):864-73. PubMed ID: 12911536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cyclosporin A on the damage and regeneration of the kidney after severe ischemia/reperfusion injury.
    Ysebaert DK; De Greef KE; Nouwen EJ; Verpooten GA; Eyskens EJ; De Broe ME
    Transplant Proc; 1997 Aug; 29(5):2348-51. PubMed ID: 9270757
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury.
    Ysebaert DK; De Greef KE; Vercauteren SR; Ghielli M; Verpooten GA; Eyskens EJ; De Broe ME
    Nephrol Dial Transplant; 2000 Oct; 15(10):1562-74. PubMed ID: 11007823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background.
    Dragun D; Hoff U; Park JK; Qun Y; Schneider W; Luft FC; Haller H
    Kidney Int; 2000 Nov; 58(5):2166-77. PubMed ID: 11044238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycophenolate mofetil].
    Abramowicz D; Broeders N; Wissing M; Sternon J
    Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
    Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
    Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat.
    Valentin JF; Bruijn JA; Paul LC
    Transplantation; 2000 Feb; 69(3):344-50. PubMed ID: 10706040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of nephrotoxic drugs.
    Alsina J
    Transplant Proc; 1999; 31(1-2):1117-9. PubMed ID: 10083499
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA; Gómez E; Rodriguez M; Laures AS; Baltar J; Grande JA
    Nephron; 2002 May; 91(1):173-4. PubMed ID: 12021539
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
    Dias PH; Oliveira GA; Dias FG; Gomes Rde P; Tambara Filho R; Fraga Rd
    Acta Cir Bras; 2015 Feb; 30(2):127-33. PubMed ID: 25714692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress with cyclosporine-sparing regimens.
    Grinyó JM
    Transplant Proc; 1999 Dec; 31(8A):11S-16S. PubMed ID: 10616555
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
    Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury.
    Gonçalves GM; Cenedeze MA; Feitoza CQ; de Paula CB; Marques GD; Pinheiro HS; de Paula Antunes Teixeira V; Antônia dos Reis M; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):417-20. PubMed ID: 17362745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity.
    Shaheen FA; Sheikh IA
    Transplant Proc; 1999 Dec; 31(8):3294. PubMed ID: 10616481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.